An official website of the United States government
Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
Weekly / March 17, 2023 / 72(11);292
On December 16, 2022, MMWR published “Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022” (1). On January 25, 2023, one of the sites contributing data to the analysis notified CDC co-authors about an error in reporting history of receipt of bivalent doses. MMWR was notified about these concerns on February 10, 2023. The site corrected its vaccination history reporting, and the authors have corrected the report and confirmed that the reporting issue did not change the interpretation or the conclusions of the original report. In accordance with December 2017 guidance from the International Committee of Medical Journal Editors (2), MMWR is republishing the report (3). The republished report includes the original report with clearly marked corrections as supplementary materials.
References
- Tenforde MW, Weber ZA, Natarajan K, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults—VISION Network, nine states, September–November 2022. MMWR Morb Mortal Wkly Rep 2022;71:1616–24. https://doi.org/10.15585/mmwr.mm715152e1 PMID:36580430
- International Committee of Medical Journal Editors (ICMJE). Corrections, retractions, republications and version control. Vancouver, Canada: International Committee of Medical Journal Editors (ICMJE); 2017. https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html
- Tenforde MW, Weber ZA, Natarajan K, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults—VISION Network, nine states, September–November 2022. MMWR Morb Mortal Wkly Rep 2022;71:1637–47. Corrected and republished from: MMWR Morb Mortal Wkly Rep 2022;71:1616–24 https://www.cdc.gov/mmwr/volumes/71/wr/mm7153a1.htm?s_cid=mm7153a1_w https://doi.org/10.15585/mmwr.mm715152e1
Suggested citation for this article: Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022. MMWR Morb Mortal Wkly Rep 2023;72:292. DOI: http://dx.doi.org/10.15585/mmwr.mm7211a6.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.